Antigen Presentation and T cell Programming in Human Autoimmune Diseases

人类自身免疫性疾病中的抗原呈递和 T 细胞编程

基本信息

  • 批准号:
    9330054
  • 负责人:
  • 金额:
    $ 165.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-09-30 至 2020-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Antigen presentation is an integral component of every autoimmune disease process, and thus represents an important scientific and clinical problem. The seven investigators who come together in this PPG have highly complementary areas of expertise and have formed a cohesive, multidisciplinary program. The overarching hypothesis is that the development and progression of autoimmune diseases are controlled by specialized populations of antigen-presenting cells (APCs) that serve distinct roles in the induction of different effector and regulatory T cell programs. The team emphasizes direct investigation of APC - T cell interactions in patients with autoimmune diseases, in particular multiple sclerosis (MS), and integrates these human immunological studies with in-depth mechanistic studies in relevant animal models. During the previous funding period, the group developed a novel nanowell-based technology platform for multiplexed investigation of T cell function in autoimmune diseases. The technology enables co-culture of single T cells with mature dendritic cells in wells of subnanoliter volume for multi-dimensional characterization of cytokine secretion and surface markers. Furthermore, responding T cells can be recovered with a robotic device for characterization of transcriptional programs. This technique will be used by all investigators to examine the functional consequences of T cell interactions with distinct populations of APC. The team will address a long-standing challenge in the field and define the functional and molecular differences between self-reactive T cells in patients with MS and healthy subjects. Studies in MS CNS lesions and animal models will examine how the interaction of T cells with different populations of APCs results in the formation of chronic inflammatory microenvironments in the target organ. Of particular interest is the complex interplay between T cells, B cells and stromal cells that results in the formation of ectopic lymphoid follicles in the CNS. Studies during the previous funding period have shown that Th17 cells express podoplanin (PDPN), a surface molecule that interacts with CLEC-2 on B cells and mature dendritic cells. Antibody-based blockade of PDPN function prevents formation of ectopic lymphoid follicles, and the function of these molecules will now be studied in MS lesions and conditional knock-out mice. The program is highly synergistic based on our focus on an important problem in the autoimmunity field, and our highly collaborative approach integrates a unique team of investigators with expertise in molecular and cellular immunology, biophysics, and engineering to investigate disease mechanisms in autoimmunity with cutting-edge technologies.
描述(由申请人提供):抗原呈递是每种自身免疫性疾病过程中不可或缺的组成部分,因此代表了一个重要的科学和临床问题。参加PPG的七名研究人员在专业领域高度互补,并形成了一个有凝聚力的多学科项目。总体假设是,自身免疫性疾病的发展和进展是由抗原呈递细胞(APC)的特化群体控制的,所述APC在诱导不同的效应和调节T细胞程序中起不同的作用。该团队强调直接研究自身免疫性疾病患者的APC - T细胞相互作用,特别是多发性硬化症(MS),并将这些人类免疫学研究与相关动物模型的深入机制研究相结合。在上一个资助期间,该小组开发了一种新型的基于T细胞的技术平台,用于自身免疫性疾病中T细胞功能的多重研究。该技术能够在亚纳升体积的威尔斯孔中共培养单个T细胞与成熟树突状细胞,用于细胞因子分泌和表面标志物的多维表征。此外,可以使用机器人设备回收响应的T细胞,以表征转录程序。这项技术将被所有研究人员用来检查T细胞与不同APC群体相互作用的功能后果。该团队将解决该领域的一个长期挑战,并确定MS患者和健康受试者中自身反应性T细胞之间的功能和分子差异。MS CNS病变和动物模型的研究将研究T细胞与不同APC群体的相互作用如何导致靶器官中慢性炎症微环境的形成。特别令人感兴趣的是T细胞、B细胞和基质细胞之间的复杂相互作用,其导致CNS中异位淋巴滤泡的形成。 在之前的资助期间的研究已经表明,Th 17细胞表达podoplanin(PDPN),PDPN是一种与B细胞和成熟树突细胞上的CLEC-2相互作用的表面分子。基于抗体的PDPN功能阻断可防止异位淋巴滤泡的形成,现在将在MS病变和条件性基因敲除小鼠中研究这些分子的功能。该计划是高度协同的基础上,我们专注于在自身免疫领域的一个重要问题,我们的高度协作的方法整合了一个独特的研究人员团队,具有分子和细胞免疫学,生物物理学和工程学的专业知识,以研究疾病机制在自身免疫与尖端技术。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
  • DOI:
    10.1016/j.coi.2011.11.004
  • 发表时间:
    2012-02
  • 期刊:
  • 影响因子:
    7
  • 作者:
    Schulze MS;Wucherpfennig KW
  • 通讯作者:
    Wucherpfennig KW
Podoplanin: emerging functions in development, the immune system, and cancer.
  • DOI:
    10.3389/fimmu.2012.00283
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Astarita JL;Acton SE;Turley SJ
  • 通讯作者:
    Turley SJ
Molecular mechanisms for contribution of MHC molecules to autoimmune diseases.
  • DOI:
    10.1016/j.coi.2014.08.005
  • 发表时间:
    2014-12
  • 期刊:
  • 影响因子:
    7
  • 作者:
    Sollid, Ludvig M.;Pos, Wouter;Wucherpfennig, Kai W.
  • 通讯作者:
    Wucherpfennig, Kai W.
Cell surface display of functional human MHC class II proteins: yeast display versus insect cell display.
  • DOI:
    10.1093/protein/gzr035
  • 发表时间:
    2011-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Fei Wen;D. Sethi;K. Wucherpfennig;Huimin Zhao
  • 通讯作者:
    Fei Wen;D. Sethi;K. Wucherpfennig;Huimin Zhao
New insights into the T cell synapse from single molecule techniques.
从单分子技术对 T 细胞突触的新见解。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kai W Wucherpfennig其他文献

Cracking the code of human T-cell immunity
破解人类 T 细胞免疫的密码
  • DOI:
    10.1038/nbt.2626
  • 发表时间:
    2013-07-09
  • 期刊:
  • 影响因子:
    41.700
  • 作者:
    Christopher J Harvey;Kai W Wucherpfennig
  • 通讯作者:
    Kai W Wucherpfennig
4-1bb Enrichment Enhances Adoptive T Cell Therapy for Hematological Malignancies Using a Novel Approach for Ex Vivo Immune Cell Priming with DC/Tumor Fusion Vaccine
  • DOI:
    10.1182/blood-2023-182381
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Kathrine S Rallis;Jessica Liegel;Giulia Cheloni;Poorva Bindal;Isabella Saldarriaga;Junyan Zhang;Georges Chedid;Joseph Abirached;John G. Clohessy;Sophia Adamia;Kai W Wucherpfennig;Donald Kufe;Jacalyn Rosenblatt;David Avigan
  • 通讯作者:
    David Avigan
Randomized Phase II Trial of Dendritic Cell/AML Fusion Cell Vaccination Compared to Standard of Care Therapy in AML CR1
  • DOI:
    10.1182/blood-2024-200876
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Prateek Pophali;Giulia Cheloni;Richard M. Stone;Kai W Wucherpfennig;Aric C. Hall;Amir T. Fathi;Lina Bisharat;Emma K Logan;Yiwen Liu;Donna S. Neuberg;Malgorzata McMasters;Jessica Liegel;Jacqueline S. Garcia;Daniel J. DeAngelo;Michele Narcis;Dina Stroopinsky;Pavania Elavalakanar;Ioannis S Vlachos;Ilene A. Galinsky;Jason Pyrdol
  • 通讯作者:
    Jason Pyrdol
Advances in CD137-Enriched Adoptive T Cell Therapy for Acute Myeloid Leukemia Via Ex Vivo Immune Cell Priming with DC/AML Fusion Vaccine
  • DOI:
    10.1182/blood-2024-208563
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Kathrine S Rallis;Jessica Liegel;Giulia Cheloni;Poorva Bindal;Isabella Saldarriaga;Junyan Zhang;Georges Chedid;Joseph Abirached;Jonah Lee;John G. Clohessy;Samprity Ankita;Rajeev Relangi;Lina Bisharat;Hazal Toros;Sophia Adamia;Jasper B Lee;Donald Kufe;Kai W Wucherpfennig;Jacalyn Rosenblatt;David Avigan
  • 通讯作者:
    David Avigan

Kai W Wucherpfennig的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kai W Wucherpfennig', 18)}}的其他基金

Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
MICA 免疫逃避的治疗靶向 - NKG2D 通路
  • 批准号:
    10380449
  • 财政年份:
    2021
  • 资助金额:
    $ 165.91万
  • 项目类别:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
核心1:肿瘤处理和单细胞RNA测序核心
  • 批准号:
    10210225
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
  • 批准号:
    10029035
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
项目。
  • 批准号:
    10210221
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
  • 批准号:
    10224146
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
项目。
  • 批准号:
    10477984
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
  • 批准号:
    10400167
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
  • 批准号:
    10668947
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
项目。
  • 批准号:
    10684029
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
核心1:肿瘤处理和单细胞RNA测序核心
  • 批准号:
    10684050
  • 财政年份:
    2020
  • 资助金额:
    $ 165.91万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 165.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了